Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Jun 15, 2010


Michael Egholm has left his post as chief technology officer and vice president of research and development at 454 Life Sciences, a unit of Roche, to become chief technology officer of Pall, which provides filtration, separation, and purification products.

Todd Arnold has been promoted to vice president of development at 454 and will lead the firm's product development efforts "as we continue to launch innovative, enabling products for the sequencing market," according to a 454 spokesperson. Arnold joined 454 almost four years ago from 3M.

Heiner Dreismann has been elected to the board of directors of Myriad Genetics. From 1985 until 2006, he held several positions at Roche, including president and CEO of Roche Molecular Systems and head of global business develop of Roche Diagnostics, and was a member of Roche's global diagnostic executive committee. Dreismann holds an MS in biology and a PhD in microbiology and molecular biology from the University of Münster in Germany.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.